In vitro and ex vivo characterization of lectin-labeled Mycobacterium tuberculosis antigen-containing microspheres for enhanced oral delivery

References

• Barrow EL, Winchester GA, Staas JK, et al. Use of microsphere technology for targeted delivery of rifampin to Mycobacterium tuberculosis-infected macrophages. Antimicr Agents Chemother 1998;42:2682–9
   PubMed Web of Science ®Google Scholar
• Wallis RS, Palaci M, Vinbas S, et al. A whole blood bactericidal assay for tuberculosis. J Infect Dis 2001;183:300–3
   Web of Science ®Google Scholar
• Gardner C, Acharya T, Pablos-Mendez A. The global alliance for tuberculosis drug development – accomplishments and future directions. Clin Chest Med 2005;26:341–7
   PubMed Web of Science ®Google Scholar
• Moingeon P, Almond J, de Wilde M. Therapeutic vaccines against infectious diseases. Curr Opin Microbiol 2003;6:462–71
   PubMed Web of Science ®Google Scholar
• Yeboah KG, D’Souza MJ. Evaluation of albumin microspheres as oral delivery system for Mycobacterium tuberculosis vaccines. J Microencapsul 2009;26:166–79
   PubMed Web of Science ®Google Scholar
• Gallichan WS, Rosenthal KL. Long-lived cytotoxic T-Lymphocyte memory in mucosal tissues after mucosal but not systemic immunization. J Exp Med 1996;184:1879–90
   PubMed Web of Science ®Google Scholar
• Belyakov IM, Moss B, Strober W, Berzofsky JA. Mucosal vaccination overcomes the barrier to recombinant vaccinia immunization caused by preexisting poxvirus immunity. Proc Natl Acad Sci USA 1999;96:4512–17
   PubMed Web of Science ®Google Scholar
• O’Hagan DT, McGee JP, Holmgren J, et al. Biodegradable microparticles for oral immunization. Vaccine 1993;11:149–54
   PubMed Web of Science ®Google Scholar
• O’Hagan DT, Rahman D, Jeffery H, et al. Controlled release microparticles for oral immunization. Int J Pharm 1994;108:133–9
   Web of Science ®Google Scholar
• Maloy KJ, Donachie AM, O’Hagan DT, Mowat AM. Induction of mucosal and systemic immune responses by immunization with ovalbumin entrapped in poly(lactide-co-glycolide) microparticles. Immunology 1994;81:61–7
   Google Scholar
• Challacombe SJ, Rahman D, O’Hagan DT. Salivary, gut, vaginal and nasal antibody responses after oral immunization with biodegradable microparticles. Vaccine 1997;15:169–75
   PubMed Web of Science ®Google Scholar
• Adwell FE, Tucker IG, de Liste GW, Buddle BM. Oral delivery of Mycobacterium bovis BCG in a lipid formulation induces resistance to pulmonary tuberculosis in mice. Infect Immun 2003;71:101–8
   PubMed Web of Science ®Google Scholar
• Coupe AJ, Davis SS, Wilding IR. Variation in gastrointestinal transit of pharmaceutical dosage forms in healthy subjects. Pharm Res 1991;8:360–4
   PubMed Web of Science ®Google Scholar
• McConnell EL, Fadda HM, Basit AW. Gut instincts: explorations in intestinal physiology and drug delivery. Int J Pharm 2008;364:213–26
   PubMed Web of Science ®Google Scholar
• Fadda HM, McConnell EL, Short MD, Basit AW. Meal-induced acceleration of tablet transit through the human small intestine. Pharm Res 2009;26:356–60
   PubMed Web of Science ®Google Scholar
• Eldridge JH, Hammond JC, Meulbroek JA, et al. Controlled vaccine release in the gut-associated lymphoid tissues. 1. Orally administered biodegradable microspheres target the Peyer’s patches. J Control Rel 1990;11:205–14
   Web of Science ®Google Scholar
• Mestecky J, Moldoveanu Z, Michalek SM, et al. Current options for vaccine delivery systems by mucosal routes. J Control Rel 1997;48:243–57
   Web of Science ®Google Scholar
• Eyles JE, Gregory JE, Sharp E, et al. Intra nasal administration of poly-lactic acid microsphere co-encapsulated Yersinia pestis subunits confers protection from pneumonic plague in the mouse. Vaccine 1998;7:698–707
   Google Scholar
• Mestecky J. The common mucosal immune system and current strategies for induction of immune responses in external secretions. J Clin Immunol 1987;7:731–7
   Google Scholar
• Kiyono H, McGhee JR, Wannemuehler MJ, et al. In vitro immune responses to a T cell-dependent antigen by cultures of dissociated murine Peyer’s patch. Proc Natl Acad Sci USA 1982;79:592–602
   Google Scholar
• Montcourrier P, Lelouard H, Maury J, et al. Apical membranes from M-cells and enterocytes have different carbohydrate expression and are recognised by different monoclonal antibodies in rabbit appendix and Peyer’s patches. Biol Cell 1996;88:78–178
   Google Scholar
• Tyler PC, Foxwell AR, Kyd JM, et al. Receptor mediated targeted of M cells. Vaccine 2007;25:3204–9
   PubMed Web of Science ®Google Scholar
• Owen RL, Pierce NF, Apple RT, Cray Jr WC. M cell transport of Vibrio cholera from the intestinal lumen into Peyer’s patches: a mechanism for antigen sampling and for microbial trans-epithelial migration. J Infect Dis 1996;153:1108–18
   Google Scholar
• Sicinski P, Rowinski J, Warchol JB, et al. Poliovirus type 1 enters the human host through the intestinal M cells. Gastroenterology 1990;98:56–8
   PubMed Web of Science ®Google Scholar
• Pappo J, Ermak TH. Uptake and translocation of fluorescent latex particles by rabbit Peyer’s patch follicle epithelium: a quantitative model for M cell uptake. Clin Exp Immunol 1989;76:144–8
   PubMed Web of Science ®Google Scholar
• Bramwell VW, Perrie Y. Particulate delivery systems for vaccines. Crit Rev Therapeut Drug Carr Syst 2005;22:151–214
   PubMed Web of Science ®Google Scholar
• Mathiowitz E, Chickering D, Jacob JS, Santos C. Bioadhesive drug delivery systems. In: Mathiowitz E, ed. Encyclopedia of controlled drug delivery. vol. 1. New York: Wiley; 1999:9–44
   Google Scholar
• Shah DN, Rectenwall-Work SM, Anseth KS. The effect of bioactive hydrogels on the secretion of extracellular matrix molecules by valvular intestinal cells. Biomaterials 2008;29:2070–2
   Google Scholar
• Vasir JK, Tambwekar K, Garg S. Bioadhesive microspheres as a controlled drug delivery system. Int J Pharmaceut 2003;255:13–2
   PubMed Web of Science ®Google Scholar
• Ahuja A, Khar RK, Ali J. Mucoadhesive drug delivery systems. Drug Dev Indus Pharm 1997;23:489–515
   Web of Science ®Google Scholar
• Lee JW, Park JH, Robinson JR. Bioadhesive based dosage forms: the next generation. J Pharmaceut Sci 2000;89:850–66
   PubMed Web of Science ®Google Scholar
• Rodriguez FL, Abraham SC, Allen MS, Sebo TI. Fine-needle aspiration cytology findings from a case of pancreatic heterotopia at the gastrointestinal junction. Diagn Cytopathol 2004;31:175–9
   PubMed Web of Science ®Google Scholar
• Lubben Van Der IM, Opdorp FAC. Transport of chitosan microparticles for mucosal vaccine delivery in a human intestinal model. J Drug Target 2002;10:449–56
   PubMed Web of Science ®Google Scholar
• Rieux D, Ragnarsson E. Transport of nanoparticles across an in vitro model of the human intestinal follicle associated epithelium. Eur J Pharmaceut Sci 2005;25:455–65
   PubMed Web of Science ®Google Scholar
• Clark AM, Jepson AM. Exploiting M cells for drug and vaccine delivery. Adv Drug Deliv Rev 2001;50:81–106
   PubMed Web of Science ®Google Scholar
• O’Hagan TD. The intestinal uptake of particles and the implications for drug and antigen delivery. J Anat 1996;189:477–82
   PubMed Web of Science ®Google Scholar
• Haas J, Lehr CM. Developments in the area of bioadhesive drug delivery systems. Expert Opin 2002;2:287–98
   Google Scholar
• Roth-Water F, Scholl I. Mucosal targeting of allergen-loaded microspheres by Aleuria aurantia lectin. Vaccine 2005;23:2703–11
   PubMed Web of Science ®Google Scholar
• Foster N, Clark AM. Ulex europaeus l lectin targets microspheres to mouse Peyer’s patch M-cells in vivo. Vaccine 1998;16:536–41
   PubMed Web of Science ®Google Scholar
• Giannasca QJ, Giannasca KT, Leightner AM, Neutra MR. Human intestinal M cells display the Sialyl Lewis A antigen. Infect Immun 1999;67:946–53
   PubMed Web of Science ®Google Scholar
• Gullberg E, Leonard M, Karlson J. Expression of specific markers and particle transport in a new human intestinal M-cell model. Biochem Biophys Res Commun 2000;279:808–13
   PubMed Web of Science ®Google Scholar
• Kerneis S, Bogdanova A, Kraehenbuhl JP, Pringault E. Conversion by Peyer’s patch lymphocytes of human enterocutes into M cells that transport bacteria. Science 1997;277:949–52
   PubMed Web of Science ®Google Scholar
• Usui N, Ray CJ, Drongowski RA, et al. The effect of phospholipids and mucin on bacterial internalization in an enterocyte-cell culture model. Pediatr Surg Int 1999;15:150–4
   PubMed Web of Science ®Google Scholar
• Akande J, Yeboah KG, Addo RT, et al. Targeted delivery of antigens to the gut-associated lymphoid tissues: 2. Ex vivo evaluation of lectin-labeled albumin microspheres for targeted delivery of antigens to the M-cells of the Peyer’s patches. J Microencaps 2010;27:325–36
   PubMed Web of Science ®Google Scholar
• Pappo C, Ermak TH, Steger HJ. Monoclonal antibody directed targeting of fluorescent microspheres to Peyer’s patches M cells. Immunology 1991;73:929–32
   Google Scholar
• Florence AT, Hillery AM, Hussain N, Jani PU. Nanoparticles as carriers for oral peptide absorption studies on particle uptake and fate. J Control Rel 1995;36:39–46
   Web of Science ®Google Scholar
• Ezpeleta I, Arangoa MA, Irache MJ, et al. Preparation of Ulex europaues lectin-gliading nanoparticles conjugates and their interaction with gastrointestinal mucus. Int J Pharmaceut 1999;191:25–32
   PubMed Web of Science ®Google Scholar
• Eldridge JH, Hammond JC, Meulbroek JA, et al. Controlled vaccine release in the gut-associated lymphoid tissues. 1. Orally administered biodegradable microspheres target the Peyer’s patches. J Control Rel 1990;11:205–14
   Web of Science ®Google Scholar
• Beier R, Gebert A. Kinetics of particle uptake in the domes of Peyer’s patches. Am J Physiol 1998;275:G130–7
   PubMed Web of Science ®Google Scholar